MEKENNA MROSKEY: Open Payments
NPI 1134517303 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 55 payments from 29 companies in 2025. Trend: 2023 $53 · 2024 $56 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $172 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Incyte Corporation | 4 | $106 |
| Celgene Corporation | 3 | $83 |
| Janssen Biotech, Inc. | 3 | $82 |
| Genentech USA, Inc. | 3 | $77 |
| PFIZER INC. | 3 | $73 |
| Daiichi Sankyo Inc. | 3 | $73 |
| Stemline Therapeutics Inc. | 1 | $56 |
| BeOne Medicines USA, Inc. | 2 | $49 |
Products named: KEYTRUDA, ENHERTU, REBLOZYL, JAKAFI, Orserdu, Polivy, PADCEV, Lenvima.
Industry payments across CA — which companies pay providers there.
